2025 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
Thoughts from Geoff Meyerson This past two weeks I had the privilege of visiting Japan and China, hosted by Locust
LOCUST WALK NEWS Bausch Health to Acquire DURECT Corporation DURECT’s lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough
Podcast: Play in new window | Download (Duration: 7:34 — 17.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 29 of Biotalk, Geoff shares insights into key trends and developments shaping the biotech landscapes in
During Episode 28 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q2 Report: Global Trends in Biopharma
2025 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Podcast: Play in new window | Download (Duration: 7:47 — 17.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 27 of Biotalk, Geoff Meyerson, CEO of Locust Walk, steps back to examine the macro forces shaping the
During the Asia-focused Episode 26 of Biotalk, Geoff Meyerson, CEO of Locust Walk, shares fresh insights from Japan, China, and Korea,
Podcast: Play in new window | Download (Duration: 13:17 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 25 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q1 Report: Global Trends in Biopharma